CPC A61K 39/215 (2013.01) [A61P 37/04 (2018.01); A61K 2039/545 (2013.01); A61K 2039/55555 (2013.01)] | 16 Claims |
1. An adjuvanted protein vaccine comprising: a SARS-CoV-2 variant C.1.2 modified S1 Spike protein sequence and a non-phospholipid liposome, wherein the protein is encapsulated within the non-phospholipid liposome.
|